Jianpi Huayu Decoction enhances the effect of sorafenib and alleviates adverse events in hepatocellular carcinoma by remodeling the gut microbiota

Background: There is an urgent need for effective treatment for advanced hepatocellular carcinoma (HCC). Sorafenib, a multi-kinase inhibitor, is the first-line treatment for advanced HCC, which has a modest efficacy due to severe adverse effects (AEs), acquired resistance, and others. Jianpi Huayu D...

Full description

Saved in:
Bibliographic Details
Main Authors: Xue Deng (Author), Yingjie Xie (Author), Yantong Lu (Author), Xueyan Li (Author), Xuan Guo (Author), Xuhui Huang (Author), Xiaohe Lan (Author), Juze Lin (Author), Wei Tan (Author), Changjun Wang (Author)
Format: Book
Published: Elsevier, 2022-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available